EUVIMEDEUVIMED entdecken
Crossref

Hypothalamic Glucose Hypersensitivity-Induced Insulin Secretion in the Obese Zücker Rat Is Reversed by Central Ghrelin Treatment

Lionel Carneiro, Claire Fenech, Fabienne Liénard, Sylvie Grall, Besma Abed, Joulia Haydar, Camille Allard, Lucie Desmoulins, Romain Paccoud, Marie-Claude Brindisi, Thomas Mouillot, Laurent Brondel und 4 weitere

Antioxidants & Redox Signaling · 2024

DOI: 10.1089/ars.2022.0031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants & Redox Signaling, 2024. Verfasst von Lionel Carneiro und 15 weiteren Autor:innen. Beteiligte Einrichtung: Centre des Sciences du Goût et de l'Alimentation, UMR Université de Bourgogne, CNRS 6265, INRAE 1324, Université Bourgogne Franche-Comté, Dijon, Fran…. Hauptthemen laut MEDLINE: Ghrelin, Hypothalamus, Obesity, Reactive Oxygen Species. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Part of hypothalamic (mediobasal hypothalamus [MBH]) neurons detect changes in blood glucose levels that in turn coordinate the vagal control of insulin secretion. This control cascade requires the production of mitochondrial reactive oxygen species (mROS), which is altered in models of obesity and insulin resistance. Obese, insulin-resistant Zücker rats are characterized by hypothalamic hypersensitivity to glucose. This initiates an abnormal vagus-induced insulin secretion, associated with an overproduction of mROS in response to a low glucose dose. Here, we hypothesized that ghrelin, known to buffer reactive oxygen species (ROS) via mitochondrial function, may be a major component of the hypothalamic glucose hypersensitivity in the hypoghrelinemic obese Zücker rat.

Results

Hypothalamic glucose hypersensitivity-induced insulin secretion of Zücker obese rats was reversed by ghrelin pretreatment. The overproduction of MBH mROS in response to a low glucose load no longer occurred in obese rats that had previously received the cerebral ghrelin infusion. This decrease in mROS production was accompanied by a normalization of oxidative phosphorylation (OXPHOS). Conversely, blocking the action of ghrelin with a growth hormone secretagogue receptor antagonist in a model of hyperghrelinemia (fasted rats) completely restored hypothalamic glucose sensing-induced insulin secretion that was almost absent in this physiological situation. Accordingly, ROS signaling and mitochondrial activity were increased by the ghrelin receptor antagonist. Innovation: These results demonstrate for the first time that ghrelin addressed only to the brain could have a protective effect on the defective control of insulin secretion in the insulin-resistant, hypoghrelinemic obese subject.

Conclusions

Ghrelin, through its action on OXPHOS, modulates mROS signaling in response to cerebral hyperglycemia and the consequent vagal control of insulin secretion. In insulin-resistant obese states, brain hypoghrelinemia could be responsible for the nervous defect in insulin secretion.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GhrelinHypothalamusObesityReactive Oxygen SpeciesGlucoseInsulin SecretionRats, ZuckerAnimalsRatsMaleMitochondriaInsulinInsulin Resistance

Stichwörter der Autor:innen

ROSbrain glucose sensingghrelininsulin resistancemitochondriaobesity

Substanzen

GhrelinReactive Oxygen SpeciesGlucoseInsulin

Autor:innen und Institutionen

  • Centre des Sciences du Goût et de l'Alimentation, UMR Université de Bourgogne, CNRS 6265, INRAE 1324, Université Bourgogne Franche-Comté, Dijon, France.
  • INSERM U1220, Institut de Recherche en Santé Digestive (IRSD), Université Paul Sabatier, Toulouse III, CHU Purpan, Toulouse, France.
  • University of Bordeaux, INSERM U1215, Neurocentre Magendie, Bordeaux, France.
  • Department of Physiology, School of Medicine, Tulane University, New Orleans, Louisiana, USA.
  • NutriNeuro, UMR 1286 INRAE, Bordeaux University, Bordeaux INP, Neurocampus, Bordeaux, France.
  • STROMALab, CNRS ERL 5311, Toulouse, France.

ORCID-Profile: Corinne Leloup

Zitieren

APA

Carneiro, L., Fenech, C., Liénard, F., Grall, S., Abed, B., Haydar, J., Allard, C., Desmoulins, L., Paccoud, R., Brindisi, M. C., Mouillot, T., Brondel, L., Fioramonti, X., Pénicaud, L., Jacquin-Piques, A., & Leloup, C. (2024). Hypothalamic Glucose Hypersensitivity-Induced Insulin Secretion in the Obese Zücker Rat Is Reversed by Central Ghrelin Treatment. Antioxidants & Redox Signaling. https://doi.org/10.1089/ars.2022.0031

Vancouver

Carneiro L, Fenech C, Liénard F, Grall S, Abed B, Haydar J, et al. Hypothalamic Glucose Hypersensitivity-Induced Insulin Secretion in the Obese Zücker Rat Is Reversed by Central Ghrelin Treatment. Antioxidants & Redox Signaling. 2024. doi:10.1089/ars.2022.0031

BibTeX
@article{Carneiro2024,
  author = {Carneiro, Lionel and Fenech, Claire and Liénard, Fabienne and Grall, Sylvie and Abed, Besma and Haydar, Joulia and Allard, Camille and Desmoulins, Lucie and Paccoud, Romain and Brindisi, Marie-Claude and Mouillot, Thomas and Brondel, Laurent and Fioramonti, Xavier and Pénicaud, Luc and Jacquin-Piques, Agnès and Leloup, Corinne},
  title = {Hypothalamic Glucose Hypersensitivity-Induced Insulin Secretion in the Obese Zücker Rat Is Reversed by Central Ghrelin Treatment},
  journal = {Antioxidants & Redox Signaling},
  year = {2024},
  doi = {10.1089/ars.2022.0031}
}
Kostenlos starten →